Observation: Clinical Trials

1,094 trials of Observation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

472 completed, 201 unknown, 190 recruiting, 85 not yet recruiting. 73 Phase 3, 69 Not applicable, 63 Phase 2, 8 Phase 4, 5 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 373Completed 26, Active not recruiting 18, Recruiting 11, Unknown 9, Terminated 6, Not yet recruiting 2, Withdrawn 1
Not applicable69Completed 30, Unknown 13, Recruiting 11, Terminated 7, Active not recruiting 5, Not yet recruiting 2, Enrolling by invitation 1
Phase 263Recruiting 17, Completed 15, Active not recruiting 11, Unknown 8, Not yet recruiting 4, Terminated 3, Withdrawn 3, Suspended 2
Phase 48Recruiting 4, Active not recruiting 1, Completed 1, Not yet recruiting 1, Terminated 1
Early Phase 15Completed 2, Recruiting 2, Terminated 1
Phase 15Completed 3, Active not recruiting 1, Not yet recruiting 1

Follow Observation: new trials by email Literature Review of Observation trials Research Report on Observation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8
Phase 2RecruitingChildren's Oncology Group512027-05-152026-09-24
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Atezolizumab, Atezolizumab and Recombinant Human Hyaluronidase, Biospecimen Collection - Lung Non-Small Cell Carcinoma
Phase 3RecruitingNational Cancer Institute (NCI)3362027-03-022026-10-22
Randomized Phase 2 Study Of Epcoritamab Vs Watch And Wait InPatients With Previously Untreated Low Tumor Burden FollicularLymphoma
Epcoritamab, Observation - Randomized, Phase 2
Phase 2Not yet recruitingM.D. Anderson Cancer Center402027-02-122026-09-23
Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain
Biospecimen Collection, Low-Dose Aspirin, Patient Observation - Endometrial Carcinoma
Phase 4Not yet recruitingMayo Clinic202027-02-122026-08-05
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
Pembroluzimab, Observation - HPV-positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Phase 2WithdrawnDana-Farber Cancer Institute2026-12-012026-10-08
Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
Observation - Aneurysm Cerebral
Not yet recruitingMayo Clinic1002026-12-012026-01-07
Evaluation of Clinical Decision Support in Opioid Tapering
Observational study without a prospective intervention - Medication Abuse, Harm Reduction
Not yet recruitingUniversity of Colorado, Denver2000002026-11-012026-09-30
China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
Tumor resection followed by aneurysm treatment, Aneurysm treatment followed by tumor resection, Observation - Unruptured Intracranial Aneurysms, Pituitary Neuroendocrine Tumor
Active not recruitingCheng sen6082026-10-202026-10-21
New Hearing Aid Users and Their Social Participation
Observation - Hearing Loss, Hearing Aids
Not yet recruitingUniversity of Nottingham322026-10-012026-10-08
Metabolites in Blood and Breath in Metabolic Conditions
Observational Study - Inborn Errors of Metabolism, Epilepsy (Treatment Refractory)
Not yet recruitingUniversity Children's Hospital, Zurich1002026-10-012026-08-12
Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study
Observation without surgery, Standard-of-care surgery - Non-Small Cell Lung Cancer, Immunotherapy
Phase 1Not yet recruitingCentre hospitalier de l'Université de Montréal (CHUM)142026-10-012026-08-14
Prospective Registry of Exposure to Gepotidacin (PREG)
None (Observational study) - Sexually Transmitted Diseases
Not yet recruitingGlaxoSmithKline6142026-09-302026-09-30
A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma
No intervention (observational study) - Uterine Fibroid, Uterine Sarcoma
Not yet recruitingTongji Hospital5002026-09-302026-10-08
Evaluation of Anterior Neck Ultrasound in Predicting Difficult Airway in Obese Patients
None (Observational study) - Ultrasonography, Airway Management
Not yet recruitingGaziantep City Hospital522026-09-202026-09-10
Japanese Strabismus Outcomes Assessment and Research Group Study
Strabismus Surgery, Conservative Treatment or Observation - Strabismus
Not yet recruitingKyoto University, Graduate School of Medicine100002026-09-012026-08-13
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
None ( observational study ) - Transthyretin Amyloidosis, Transthyretin Amyloidosis With Cardiomyopathy
RecruitingAstraZeneca3202026-09-012026-09-14
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery
Observation, Endocrine Therapy (Optional) - Ductal Carcinoma In Situ, DCIS
Phase 2RecruitingFudan University2342026-09-012026-08-13
HCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B
No intervention (observational study) - Hepatocellular Carcinoma (HCC)
Not yet recruitingBeijing Friendship Hospital20002026-08-202026-08-28
REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With Hypertension
observational study - Hypertension, Aldosterone Disorder
RecruitingKaiser Permanente5002026-08-202026-10-05

Showing 20 of 1094. Sign in to see all of them.

Conditions studied

Obesity (24)  ·  COVID-19 (23)  ·  Stroke (23)  ·  Prostatic Neoplasms (22)  ·  Breast Neoplasms (21)  ·  Carcinoma, Non-Small-Cell Lung (21)  ·  Neoplasms (20)  ·  Cardiovascular Diseases (16)  ·  Colorectal Neoplasms (16)  ·  Heart Failure (16)  ·  Diabetes Mellitus, Type 2 (15)  ·  Stomach Neoplasms (15)  ·  Arthritis, Rheumatoid (13)  ·  Depression (13)  ·  Lung Neoplasms (13)

Sponsors

National Cancer Institute (NCI) (23)  ·  AstraZeneca (16)  ·  Mayo Clinic (12)  ·  Peking Union Medical College Hospital (11)  ·  Children's Oncology Group (9)  ·  Fudan University (9)  ·  National Taiwan University Hospital (9)  ·  Sun Yat-sen University (9)  ·  Assiut University (7)  ·  M.D. Anderson Cancer Center (7)  ·  Sohag University (7)  ·  University of Zurich (7)  ·  Charite University, Berlin, Germany (6)  ·  Chinese University of Hong Kong (6)  ·  Oslo University Hospital (6)

Countries

United States (271)  ·  China (149)  ·  Italy (71)  ·  France (66)  ·  Turkey (Türkiye) (62)  ·  Canada (56)  ·  Germany (52)  ·  United Kingdom (50)  ·  Spain (34)  ·  Switzerland (32)  ·  Netherlands (29)  ·  Brazil (27)  ·  Taiwan (27)  ·  Egypt (24)  ·  Denmark (23)

Top investigators

Franca Fagioli, MD (4)  ·  Angela Jefferson, PhD (2)  ·  Carsten Skarke, MD (2)  ·  Garret A FitzGerald, MD (2)  ·  George C Fox (2)  ·  Harlan M Krumholz, MD, SM (2)  ·  Henrik Gregersen, MD (2)  ·  Hom-Lay Wang, DDS MSD PhD (2)  ·  Jing Li, MD, PhD (2)

Results publications

PMID 40881041, PMID 41911908, PMID 42335416, PMID 10329105, PMID 11114637, PMID 11535886, PMID 11570715, PMID 11576374, PMID 11596161, PMID 11680441, PMID 11762335, PMID 11996444, PMID 12091180, PMID 12583868, PMID 13105270, PMID 13126521, PMID 14609712, PMID 1494764, PMID 15293766, PMID 15561396, PMID 15867769, PMID 16096555, PMID 16167048, PMID 16282778, PMID 16390886, PMID 16391218, PMID 16403930, PMID 16461781, PMID 16680602, PMID 16757203, PMID 16994214, PMID 16994980, PMID 17074942, PMID 17184516, PMID 17227526, PMID 17262200, PMID 17470624, PMID 17554118, PMID 17629661, PMID 18178467, PMID 18506026, PMID 18728566, PMID 19029209, PMID 19034057, PMID 19061172, PMID 19436079, PMID 19494162, PMID 19671919, PMID 19777259, PMID 19801201

NIH funding

U10CA180820 (10), U10CA180821 (7), U10CA180886 (7), U10CA180868 (6), U10CA021115 (5), U10CA098543 (4), U10CA180888 (4), 2023 (3), U10CA031946 (3), P30CA138292 (2), U10CA027469 (2), U10CA180830 (2), 2016 (1), 2018 (1), 2019 (1)